Skip to content
Parakho

Dr. Agarwals Health Care Ltd

NSE AGARWALEYEBSE 544350dragarwals.co.in

Q1 FY27, unaudited

Revenue
₹614.02 Cr
Profit after tax
₹55.02 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations614.02+25.97%2,080.08
Other income6.41−52.13%44.44
Total income620.43+23.89%2,124.52
Employee benefit expense121.04+26.72%403.79
Finance costs23.37−5.38%90.46
Depreciation & amortisation78.31+24.40%276.24
Total expenses545.29+21.93%1,877.21
Profit before tax75.14+40.19%248.64
Tax expense20.12+29.47%80.50
Profit after tax55.02+44.56%168.14
Total comprehensive income57.37+27.74%185.74
Earnings per share
Earnings per share, basic₹1.43₹4.21
Earnings per share, diluted₹1.42₹4.18

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Dr. Agarwal's Healthcare reported Q1 FY27 revenue from operations of INR614 crores, up 26% year-on-year, with Ind AS EBITDA of INR177 crores at a 28.5% margin. The company launched 18 new facilities including 16 surgical centers, its highest ever in a single quarter, taking the network to 285 facilities across 14 states. Management discussed regional performance, same-store sales growth trends, doctor additions, and provided an update on the pending merger.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 49 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.